EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

The Impact of Standard Versus Weight‐Based Maintenance Dosing of Fosphenytoin on Achieving Therapeutic Drug Levels

Madison Milby, Theresa Kwarciany iD, Lindsey Jarboe, Lindsay Weitkamp iD

The Journal of Clinical Pharmacology · 2025

DOI: 10.1002/jcph.70050 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Pharmacology, 2025. Verfasst von Madison Milby und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, UofL Health-University of Louisville Hospital, Louisville, KY, USA. Hauptthemen laut MEDLINE: Anticonvulsants, Phenytoin, Body Weight. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fosphenytoin is an antiepileptic drug (AED) used for the treatment of many seizure subtypes as well as seizure prophylaxis. Dosing of fosphenytoin has traditionally been weight‐based, however, there is data to support standard dosing, making the optimal dosing strategy unclear. The purpose of this study was to evaluate the impact of standard versus weight‐based maintenance dosing of fosphenytoin on achieving therapeutic serum phenytoin levels.

Methods

This was a retrospective review of patients admitted at two medical centers between January 1, 2021, and October 31, 2023 who received fosphenytoin maintenance therapy. Patients were divided into two groups based on initial maintenance dose: standard dosing (100 mg every 8 h) and weight‐based dosing. The primary outcome was the incidence of the first serum phenytoin level being therapeutic.

Results

A total of 92 patients with an average age of 56.9 years were included, 47 patients in the weight‐based dosing group and 45 patients in the standard dosing group. The mean corrected total and free phenytoin levels were 12.8 and 1.6 mcg/mL respectively in the weight‐based dosing group compared to 12.1 and 1.45 mcg/mL in the standard dosing group. A total of 32 patients in the weight‐based dosing group had a therapeutic level compared to 25 patients in the standard dosing group, which was not significantly different (68% versus 55.6%, P = 0.283).

Conclusion

This study found no difference in the incidence of first serum phenytoin level being therapeutic based on fosphenytoin dosing strategy utilized. Further prospective studies should be conducted to evaluate fosphenytoin maintenance dosing strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsPhenytoinBody WeightHumansMiddle AgedMaleFemaleRetrospective StudiesAgedAdultSeizuresDose-Response Relationship, Drug

Stichwörter der Autor:innen

fosphenytoinneurologypharmacokinetics and drug monitoringphenytointherapeutic drug monitoring

Substanzen

AnticonvulsantsfosphenytoinPhenytoin

Autor:innen und Institutionen

  • Department of Pharmacy, UofL Health-University of Louisville Hospital, Louisville, KY, USA.
  • University of Kentucky College of Pharmacy, Lexington, KY, USA.

ORCID-Profile: Theresa Kwarciany, Lindsay Weitkamp

Zitieren

APA

Milby, M., Kwarciany, T., Jarboe, L., & Weitkamp, L. (2025). The Impact of Standard Versus Weight‐Based Maintenance Dosing of Fosphenytoin on Achieving Therapeutic Drug Levels. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70050

Vancouver

Milby M, Kwarciany T, Jarboe L, Weitkamp L. The Impact of Standard Versus Weight‐Based Maintenance Dosing of Fosphenytoin on Achieving Therapeutic Drug Levels. The Journal of Clinical Pharmacology. 2025. doi:10.1002/jcph.70050

BibTeX
@article{Milby2025,
  author = {Milby, Madison and Kwarciany, Theresa and Jarboe, Lindsey and Weitkamp, Lindsay},
  title = {The Impact of Standard Versus Weight‐Based Maintenance Dosing of Fosphenytoin on Achieving Therapeutic Drug Levels},
  journal = {The Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/jcph.70050}
}
Kostenlos starten →